Documents

  1. Home
    2. »
  2. Conferences and Webinars
    3. »
  3. 2025
    4. »
  4. 2nd IABS Real World Evidence Workshop : The Role of Alternative Approaches to Phase 3 Clinical Trials for Vaccine Efficacy and Licensure

Folder 2nd IABS Real World Evidence Workshop : The Role of Alternative Approaches to Phase 3 Clinical Trials for Vaccine Efficacy and Licensure

Folder Abstracts  (12)

Folder Biosketches  (1)

  1. Home
    2. »
  2. Conferences and Webinars
    3. »
  3. 2025
    4. »
  4. 2nd IABS Real World Evidence Workshop : The Role of Alternative Approaches to Phase 3 Clinical Trials for Vaccine Efficacy and Licensure
    5. »
  5. D1 10 Panel Discussion Dealing with uncertainty in vaccine benefit at initial approval and its consequences

pdf D1 10 Panel Discussion Dealing with uncertainty in vaccine benefit at initial approval and its consequences

By 93 downloads

Download (pdf, 848 KB)

10. Panel Discussion – Dealing with uncertainty in vaccine benefit at initial approval and its consequences.pdf

D1 10 Panel Discussion Dealing with uncertainty in vaccine benefit at initial approval and its consequences
  1. Home
    2. »
  2. Conferences and Webinars
    3. »
  3. 2025
    4. »
  4. 2nd IABS Real World Evidence Workshop : The Role of Alternative Approaches to Phase 3 Clinical Trials for Vaccine Efficacy and Licensure
    5. »
  5. D1 12. K. BOLLAERTS – Real-World Evidence from observational studies to pragmatic trials, supporting initial licensure to label expansion

pdf D1 12. K. BOLLAERTS – Real-World Evidence from observational studies to pragmatic trials, supporting initial licensure to label expansion

By 138 downloads

Download (pdf, 252 KB)

12KBOL~1.PDF

D1 12. K. BOLLAERTS - Real-World Evidence from observational studies to pragmatic trials, supporting initial licensure to label expansion
  1. Home
    2. »
  2. Conferences and Webinars
    3. »
  3. 2025
    4. »
  4. 2nd IABS Real World Evidence Workshop : The Role of Alternative Approaches to Phase 3 Clinical Trials for Vaccine Efficacy and Licensure
    5. »
  5. D1 13 V JENKINS Real World Evidence to confirm vaccine benefit Mpox Vaccine

pdf D1 13 V JENKINS Real World Evidence to confirm vaccine benefit Mpox Vaccine

By 131 downloads

Download (pdf, 1.27 MB)

13. V. JENKINS – Real-World Evidence to confirm vaccine benefit Mpox Vaccine.pdf

D1 13 V JENKINS Real World Evidence to confirm vaccine benefit Mpox Vaccine
  1. Home
    2. »
  2. Conferences and Webinars
    3. »
  3. 2025
    4. »
  4. 2nd IABS Real World Evidence Workshop : The Role of Alternative Approaches to Phase 3 Clinical Trials for Vaccine Efficacy and Licensure
    5. »
  5. D1 14 I BARTALESI Real World Evidence to confirm vaccine benefit Meningococcal B vaccine

pdf D1 14 I BARTALESI Real World Evidence to confirm vaccine benefit Meningococcal B vaccine

By 99 downloads

Download (pdf, 840 KB)

14. I. BARTALESI – Real-World Evidence to confirm vaccine benefit- Meningococcal B vaccine.pdf

D1 14 I BARTALESI Real World Evidence to confirm vaccine benefit Meningococcal B vaccine
  1. Home
    2. »
  2. Conferences and Webinars
    3. »
  3. 2025
    4. »
  4. 2nd IABS Real World Evidence Workshop : The Role of Alternative Approaches to Phase 3 Clinical Trials for Vaccine Efficacy and Licensure
    5. »
  5. D1 15 KRAUSE P Ebola

pdf D1 15 KRAUSE P Ebola

By 128 downloads

Download (pdf, 1.01 MB)

15 – KRAUSE P. Ebola.pdf

D1 15 KRAUSE P Ebola
  1. Home
    2. »
  2. Conferences and Webinars
    3. »
  3. 2025
    4. »
  4. 2nd IABS Real World Evidence Workshop : The Role of Alternative Approaches to Phase 3 Clinical Trials for Vaccine Efficacy and Licensure
    5. »
  5. D1 16 V JENKINS Real World Evidence to confirm vaccine benefit Chikungunya vaccine

pdf D1 16 V JENKINS Real World Evidence to confirm vaccine benefit Chikungunya vaccine

By 118 downloads

Download (pdf, 1.71 MB)

16. V. JENKINS – Real-World Evidence to confirm vaccine benefit Chikungunya vaccine.pdf

D1 16 V JENKINS Real World Evidence to confirm vaccine benefit Chikungunya vaccine
  1. Home
    2. »
  2. Conferences and Webinars
    3. »
  3. 2025
    4. »
  4. 2nd IABS Real World Evidence Workshop : The Role of Alternative Approaches to Phase 3 Clinical Trials for Vaccine Efficacy and Licensure
    5. »
  5. D1 18 TUBOI Suely Progress of the post approval efffectiveness

pdf D1 18 TUBOI Suely Progress of the post approval efffectiveness

By 114 downloads

Download (pdf, 2.09 MB)

18 – TUBOI Suely – Progress of the post approval efffectiveness.pdf

D1 18 TUBOI Suely Progress of the post approval efffectiveness
  1. Home
    2. »
  2. Conferences and Webinars
    3. »
  3. 2025
    4. »
  4. 2nd IABS Real World Evidence Workshop : The Role of Alternative Approaches to Phase 3 Clinical Trials for Vaccine Efficacy and Licensure
    5. »
  5. D1 19 B GESSNER Real World Evidence to confirm vaccine benefit Next generation pneumococcal vaccines

pdf D1 19 B GESSNER Real World Evidence to confirm vaccine benefit Next generation pneumococcal vaccines

By 140 downloads

Download (pdf, 1.01 MB)

19. B. GESSNER – Real-World Evidence to confirm vaccine benefit Next generation pneumococcal vaccines.pdf

D1 19 B GESSNER Real World Evidence to confirm vaccine benefit Next generation pneumococcal vaccines
  1. Home
    2. »
  2. Conferences and Webinars
    3. »
  3. 2025
    4. »
  4. 2nd IABS Real World Evidence Workshop : The Role of Alternative Approaches to Phase 3 Clinical Trials for Vaccine Efficacy and Licensure
    5. »
  5. D1 2 P NEELS Opening of the meeting

pdf D1 2 P NEELS Opening of the meeting

By 106 downloads

Download (pdf, 2.76 MB)

2. P. NEELS – Opening of the meeting.pdf

D1 2 P NEELS Opening of the meeting
  1. Home
    2. »
  2. Conferences and Webinars
    3. »
  3. 2025
    4. »
  4. 2nd IABS Real World Evidence Workshop : The Role of Alternative Approaches to Phase 3 Clinical Trials for Vaccine Efficacy and Licensure
    5. »
  5. D1 20 A ALLEN Real world measurement of COVID 19 vaccine effectiveness through the pandemic and beyond

pdf D1 20 A ALLEN Real world measurement of COVID 19 vaccine effectiveness through the pandemic and beyond

By 119 downloads

Download (pdf, 1.92 MB)

20. A. ALLEN – Real world measurement of COVID-19 vaccine effectiveness through the pandemic and beyond.pdf

D1 20 A ALLEN Real world measurement of COVID 19 vaccine effectiveness through the pandemic and beyond
  1. Home
    2. »
  2. Conferences and Webinars
    3. »
  3. 2025
    4. »
  4. 2nd IABS Real World Evidence Workshop : The Role of Alternative Approaches to Phase 3 Clinical Trials for Vaccine Efficacy and Licensure
    5. »
  5. D1 21 HAYFORD Kyla RWE to confirm vaccine benefit

pdf D1 21 HAYFORD Kyla RWE to confirm vaccine benefit

By 151 downloads

Download (pdf, 2.71 MB)

21 – HAYFORD Kyla – RWE to confirm vaccine benefit.pdf

D1 21 HAYFORD Kyla RWE to confirm vaccine benefit
  1. Home
    2. »
  2. Conferences and Webinars
    3. »
  3. 2025
    4. »
  4. 2nd IABS Real World Evidence Workshop : The Role of Alternative Approaches to Phase 3 Clinical Trials for Vaccine Efficacy and Licensure
    5. »
  5. D1 3 L DE MOERLOOZE Introduction to the meeting objectives

pdf D1 3 L DE MOERLOOZE Introduction to the meeting objectives

By 133 downloads

Download (pdf, 109 KB)

3. L. DE MOERLOOZE – Introduction to the meeting objectives.pdf

D1 3 L DE MOERLOOZE Introduction to the meeting objectives
  1. Home
    2. »
  2. Conferences and Webinars
    3. »
  3. 2025
    4. »
  4. 2nd IABS Real World Evidence Workshop : The Role of Alternative Approaches to Phase 3 Clinical Trials for Vaccine Efficacy and Licensure
    5. »
  5. D1 4 L OOSTVOGELS Developing a Group B Streptococcus vaccine for maternal immunisation challenges

pdf D1 4 L OOSTVOGELS Developing a Group B Streptococcus vaccine for maternal immunisation challenges

By 127 downloads

Download (pdf, 3.45 MB)

4. L. OOSTVOGELS – Developing a Group B Streptococcus vaccine for maternal immunisation challenges.pdf

D1 4 L OOSTVOGELS Developing a Group B Streptococcus vaccine for maternal immunisation challenges
  1. Home
    2. »
  2. Conferences and Webinars
    3. »
  3. 2025
    4. »
  4. 2nd IABS Real World Evidence Workshop : The Role of Alternative Approaches to Phase 3 Clinical Trials for Vaccine Efficacy and Licensure
    5. »
  5. D1 5 D CRAIG Review of vaccines licensed in absence of a Phase 3 randomized controlled efficacy trial

pdf D1 5 D CRAIG Review of vaccines licensed in absence of a Phase 3 randomized controlled efficacy trial

By 131 downloads

Download (pdf, 1.45 MB)

5. D. CRAIG – Review of vaccines licensed in absence of a Phase 3 randomized controlled efficacy trial.pdf

D1 5 D CRAIG Review of vaccines licensed in absence of a Phase 3 randomized controlled efficacy trial
  1. Home
    2. »
  2. Conferences and Webinars
    3. »
  3. 2025
    4. »
  4. 2nd IABS Real World Evidence Workshop : The Role of Alternative Approaches to Phase 3 Clinical Trials for Vaccine Efficacy and Licensure
    5. »
  5. D1 6 M CAVALERI Summary and insights from the EMA workshop (24 25 Nov 2025) on the use of animal

pdf D1 6 M CAVALERI Summary and insights from the EMA workshop (24 25 Nov 2025) on the use of animal

By 141 downloads

Download (pdf, 2.41 MB)

6. M. CAVALERI – Summary and insights from the EMA workshop (24-25 Nov 2025) on the use of animal.pdf

D1 6 M CAVALERI Summary and insights from the EMA workshop (24 25 Nov 2025) on the use of animal
  1. Home
    2. »
  2. Conferences and Webinars
    3. »
  3. 2025
    4. »
  4. 2nd IABS Real World Evidence Workshop : The Role of Alternative Approaches to Phase 3 Clinical Trials for Vaccine Efficacy and Licensure
    5. »
  5. D1 7 R READ Evidence on vaccine benefit from Human Infection Models insights and

pdf D1 7 R READ Evidence on vaccine benefit from Human Infection Models insights and

By 126 downloads

Download (pdf, 5.02 MB)

7. R. READ – Evidence on vaccine benefit from Human Infection Models – insights and.pdf

D1 7 R READ Evidence on vaccine benefit from Human Infection Models insights and
  1. Home
    2. »
  2. Conferences and Webinars
    3. »
  3. 2025
    4. »
  4. 2nd IABS Real World Evidence Workshop : The Role of Alternative Approaches to Phase 3 Clinical Trials for Vaccine Efficacy and Licensure
    5. »
  5. D1 9 P KRAUSE Evidence on vaccine benefit based on COP

pdf D1 9 P KRAUSE Evidence on vaccine benefit based on COP

By 114 downloads

Download (pdf, 356 KB)

9 – P. KRAUSE – Evidence on vaccine benefit based on COP.pdf

D1 9 P KRAUSE Evidence on vaccine benefit based on COP
  1. Home
    2. »
  2. Conferences and Webinars
    3. »
  3. 2025
    4. »
  4. 2nd IABS Real World Evidence Workshop : The Role of Alternative Approaches to Phase 3 Clinical Trials for Vaccine Efficacy and Licensure
    5. »
  5. D2 13 Break Out What are the alternative approaches and when are they acceptable

pdf D2 13 Break Out What are the alternative approaches and when are they acceptable

By 97 downloads

Download (pdf, 848 KB)

13. Break Out – What are the alternative approaches and when are they acceptable.pdf

D2 13 Break Out What are the alternative approaches and when are they acceptable
  1. Home
    2. »
  2. Conferences and Webinars
    3. »
  3. 2025
    4. »
  4. 2nd IABS Real World Evidence Workshop : The Role of Alternative Approaches to Phase 3 Clinical Trials for Vaccine Efficacy and Licensure
    5. »
  5. D2 15 ABS RWE meeting, closing remarks

pdf D2 15 ABS RWE meeting, closing remarks

By 127 downloads

Download (pdf, 117 KB)

15. ABS RWE meeting, closing remarks.pdf

D2 15 ABS RWE meeting, closing remarks
  1. Home
    2. »
  2. Conferences and Webinars
    3. »
  3. 2025
    4. »
  4. 2nd IABS Real World Evidence Workshop : The Role of Alternative Approaches to Phase 3 Clinical Trials for Vaccine Efficacy and Licensure
    5. »
  5. D2 2 P KRAUSE Objectives of the day

pdf D2 2 P KRAUSE Objectives of the day

By 137 downloads

Download (pdf, 245 KB)

2. P. KRAUSE – Objectives of the day.pdf

D2 2 P KRAUSE Objectives of the day
IABS
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.